Griffith University’s Institute for Glycomics has developed a groundbreaking, combination vaccine that may finally beat Streptococcus A infections. Human trials are set to begin as early as next year.
Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a ground-breaking Griffith University study found...
Striking brain similarities have been detected in patients who experience Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), in particular,...
Is man flu real? Is there a valid biological reason behind men’s symptoms or are men just malingering? And how does man flu differ from flu? Professor Thea van de Martel explains.
In a world-first discovery, Griffith University researchers have discovered faulty cell function in veterans suffering from Gulf War Illness (GWI),...
Researchers from Griffith University’s National Centre for Neuroimmunology and Emerging Diseases (NCNED) have made a groundbreaking discovery that could bring...
Researchers find overlap in long COVID and ME/CFS patients using MRI.
People with Long COVID in Australia have poor health outcomes that are comparable with another emerging disease known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Griffith pays tribute to distinguished leader in immunology, academia and research.
Study suggests COVID-19 could be a potential trigger for ME/CFS.
